Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review

OBJECTIVE: The efficacy and safety of regorafenib and fruquintinib are studied extensively in different populations and trials across the world to determine their potential benefits. Here we review the efficacy and safety of regorafenib and fruquintinib as third-line treatment option for colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaojing, Yu, Yiyi, Liu, Mengling, Liang, Li, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841594/
https://www.ncbi.nlm.nih.gov/pubmed/35261903
http://dx.doi.org/10.21037/tcr-20-3539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841594/
https://www.ncbi.nlm.nih.gov/pubmed/35261903
http://dx.doi.org/10.21037/tcr-20-3539

Ejemplares similares